{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:50:14Z","timestamp":1774569014382,"version":"3.50.1"},"reference-count":37,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"PrEPVacc"},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"The Second European & Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["RIA2016\u2009\u2212\u20091644"],"award-info":[{"award-number":["RIA2016\u2009\u2212\u20091644"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UK Medical Research Council (MRC) and the UK Foreign, Common wealth, and Development Office"},{"name":"MRC\/FCDO"},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["MR\/R010161\/1"],"award-info":[{"award-number":["MR\/R010161\/1"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"crossref","award":["MC_UU_00004\/03"],"award-info":[{"award-number":["MC_UU_00004\/03"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["HIV Research & Clinical Practice"],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.1080\/25787489.2025.2513684","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:09:17Z","timestamp":1749632957000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Evaluating adherence in an active-controlled HIV pre-exposure prophylaxis trial (PrEPVacc) to inform the estimation of HIV incidence in a counterfactual placebo arm"],"prefix":"10.1080","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3700-1501","authenticated-orcid":false,"given":"Sheila","family":"Kansiime","sequence":"first","affiliation":[{"name":"Uganda Research Unit, Medical Research Council\/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine","place":["Entebbe, Uganda"]},{"name":"Medical Research Council International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine","place":["London, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Holm Hansen","sequence":"additional","affiliation":[{"name":"Medical Research Council International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine","place":["London, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Bern","sequence":"additional","affiliation":[{"name":"Medical Research Council Clinical Trials Unit","place":["London, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Fox","sequence":"additional","affiliation":[{"name":"King\u2019s College London","place":["London, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Dunn","sequence":"additional","affiliation":[{"name":"Medical Research Council Clinical Trials Unit","place":["London, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene","family":"Ruzagira","sequence":"additional","affiliation":[{"name":"Uganda Research Unit, Medical Research Council\/Uganda Virus Research Institute and London School of Hygiene and Tropical Medicine","place":["Entebbe, Uganda"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Hayes","sequence":"additional","affiliation":[{"name":"Medical Research Council International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine","place":["London, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheena","family":"Mc Cormack","sequence":"additional","affiliation":[{"name":"Medical Research Council Clinical Trials Unit","place":["London, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the PrEPVacc study team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"key":"e_1_3_8_2_1","volume-title":"Pre exposure prophylaxis","author":"World Health Organisation","year":"2022","unstructured":"World Health Organisation. Pre exposure prophylaxis. Geneva, Switzerland: World Health Organisation; 2022."},{"key":"e_1_3_8_3_1","volume-title":"Long acting injectable cabotegravir is safe and effective in preventing HIV infection in cisgender women: results from HPTN 084","author":"Sinead Delany-Moretlwe, O.B.O.T.H.S.T","year":"2021","unstructured":"Sinead Delany-Moretlwe, O.B.O.T.H.S.T. Long acting injectable cabotegravir is safe and effective in preventing HIV infection in cisgender women: results from HPTN 084. 2021. HPTN084 online material. Available from: https:\/\/www.084life.org\/wp-content\/uploads\/2021\/02\/210123-HPTN-084-HIV-R4P-final-final.pdf"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00538-4"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25744"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2407001"},{"issue":"1","key":"e_1_3_8_7_1","first-page":"20230002","article-title":"Study design approaches for future active-controlled HIV prevention trials","volume":"15","author":"Donnell D","year":"2024","unstructured":"Donnell D, Kansiime S, Glidden DV, et\u00a0al. Study design approaches for future active-controlled HIV prevention trials. Stat Commun Infect Dis. 2024;15(1):20230002.","journal-title":"Stat Commun Infect Dis"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(18)30045-6"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000386"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.9321"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01710-17"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1201"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-016-1360-7"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/15284336.2017.1379676"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad021"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30192-2"},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02564-5"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000207"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0094932"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249465"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(85)90122-9"},{"key":"e_1_3_8_22_1","volume-title":"OC 8491 prepvacc: a phase iii, mams adaptive prophylactic hiv vaccine trial with a second randomisation to compare F\/taf with tdf\/ftc prep","author":"Joseph S","year":"2019","unstructured":"Joseph S, Kaleebu P, Ruzagira E, et\u00a0al. OC 8491 prepvacc: a phase iii, mams adaptive prophylactic hiv vaccine trial with a second randomisation to compare F\/taf with tdf\/ftc prep. London: BMJ Global Health; 2019."},{"key":"e_1_3_8_23_1","unstructured":"MRC\/UVRI and LSHTM Uganda Research Unit. A combination efficacy study in Africa of two DNA-MVA-Env protein or DNA-Env protein HIV-1 vaccine regimens with PrEP (PrEPVacc (NCT04066881)). 2019. Clinical Trials.gov. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04066881"},{"key":"e_1_3_8_24_1","unstructured":"PrEPVacc. PrEPVacc. Available from: https:\/\/www.prepvacc.org\/. 2020."},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00286"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa329"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3004006"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31065-5"},{"key":"e_1_3_8_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101016"},{"key":"e_1_3_8_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001145"},{"key":"e_1_3_8_31_1","first-page":"174550572311838","article-title":"Measuring women\u2019s sexual autonomy: Development and preliminary validation of the women\u2019s sexual autonomy scale","volume":"19","author":"Willie TC","year":"2023","unstructured":"Willie TC, Callands T, Alexander KA, et\u00a0al. Measuring women\u2019s sexual autonomy: Development and preliminary validation of the women\u2019s sexual autonomy scale. Womens Health (Lond). 2023;19:17455057231183837.","journal-title":"Womens Health (Lond)"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s44197-023-00153-w"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/JNC.0000000000000021"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09660-y"},{"key":"e_1_3_8_35_1","unstructured":"Mugwanya K MN Donnell D et\u00a0al. Adherence benchmarks for TFV-DP in DBS and PBMCs for african women using FTC\/TDF PrEP. CROI 2024. Available at: https:\/\/www.croiconference.org\/abstract\/adherence-benchmarks-for-tfv-dp-in-dbs-and-pbmcs-for-african-women-using-ftc-tdf-prep\/"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-12859-w"},{"key":"e_1_3_8_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001024"},{"key":"e_1_3_8_38_1","doi-asserted-by":"publisher","DOI":"10.2196\/15029"}],"container-title":["HIV Research & Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/25787489.2025.2513684","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T06:29:36Z","timestamp":1766039376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/25787489.2025.2513684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1080\/25787489.2025.2513684"],"URL":"https:\/\/doi.org\/10.1080\/25787489.2025.2513684","relation":{},"ISSN":["2578-7489","2578-7470"],"issn-type":[{"value":"2578-7489","type":"print"},{"value":"2578-7470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhct21","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhct21","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-01-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2513684"}}